Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Steps in Outbreak Investigation

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dermatofibroma Hypocellularity Is Associated With Patient Age: A Retrospective Study of 307 Cases.

Journal of cutaneous pathology·2026

Same author

Superficial biopsies: Ethical obligations in dermatologic practice.

Journal of the American Academy of Dermatology·2026

Same author

Carcinogenesis: An Alternative Hypothesis Comparing Mutagenic Versus Metabolic Models.

Biology·2025

Same author

Secrets of the Stratum Corneum I: Parakeratosis or Porokeratosis?

Skinmed·2025

Same author

Editors and Journals: Part III-"<i>Sto Tavo</i> (Who Is In Charge)?"

Skinmed·2024

Same author

Multiple Eruptive Dermatofibromas in Systemic Lupus Erythematosus.

Skinmed·2024

Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025

Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025

Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025

Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025

Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025

Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 16, 2025

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Case Presentation: Monkeypox.

W Clark Lambert¹, Yolanda Riley², Roslyn Mandrique Banfiancila²

¹Department of Dermatology, Rutgers New Jersey Medical School, Newark, NJ; wclambert3129@gmail.com.

|December 20, 2022

Summary

This summary is machine-generated.

Monkeypox is a rare viral disease primarily transmitted from animals to humans. While uncommon, outbreaks have occurred globally, leading to health emergencies in affected areas.

More Related Videos

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Published on: April 10, 2009

Related Experiment Videos

Last Updated: Aug 16, 2025

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1

Published on: April 8, 2009

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 2

Published on: April 10, 2009

Area of Science:

Epidemiology
Infectious Diseases
Public Health

Background:

Monkeypox is a rare zoonotic viral disease originating in West and Central Africa.
The disease was first identified in the United States in 2003, marking its initial spread outside of Africa.
Despite its rarity, recent outbreaks, particularly within gay communities, have led to public health concerns and emergency declarations.

Purpose of the Study:

To provide an overview of monkeypox epidemiology.
To highlight the transmission dynamics and geographical spread of the virus.
To underscore the public health implications of monkeypox outbreaks.

Main Methods:

Review of existing literature on monkeypox.
Analysis of historical and recent outbreak data.
Epidemiological surveillance and case reporting.

Main Results:

Monkeypox is primarily transmitted from animals to humans (zoonotic).
The virus has a history of limited transmission outside of Africa, with a notable US introduction in 2003.
Recent outbreaks have been observed in specific populations, necessitating public health responses.

Conclusions:

Monkeypox, though rare, poses a potential public health threat.
Understanding transmission patterns is crucial for outbreak control.
Continued surveillance and awareness are important for managing the spread of monkeypox.